BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2016

May 4, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2016-04-29

Reporting Person: BIENAIME JEAN JACQUES (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-04-29	Common Stock	A	414	$51.264	Acquired	395635	Direct
2016-05-02	Common Stock	M	36500	$12.99	Acquired	432135	Direct
2016-05-02	Common Stock	S	36500	$85.0118	Disposed	395635	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-05-02	Stock Option (right to buy) Common Stock	$12.99	M	36500	Disposed	2016-05-10	Common Stock (36500)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	25758	Indirect

Footnotes

F1: The reporting person is reporting the purchase of shares of the issuer's Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of November 1, 2015 to April 30, 2016.

F2: Transaction made pursuant to a Rule 10b5-1 trading plan executed on August 17, 2015.

F3: The price in column 4 is a weighted average price. The price actually received ranged from $83.94 to $86.50. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F4: Reflects the numbers of stock options outstanding after the transaction from this specific stock option grant.